News
Pharma Major #BiologicalE Has Sought Approval from Drug Regulator Drugs Controller General ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'Pharma major #BiologicalE has sought approval from drug regulator Drugs Controller General of India to conduct phase-3 clinical trial of #Covid vaccine Corbevax. The Co. has sought approval as a single booster dose for those fully vaccinated with #Covishield or #Covaxin vaccines.'
Pharma major #BiologicalE has sought approval from drug regulator Drugs Controller General of India to conduct phase-3 clinical trial of #Covid vaccine Corbevax. The Co. has sought approval as a single booster dose for those fully vaccinated with #Covishield or #Covaxin vaccines. pic.twitter.com/66lXL9AWum— IANS Tweets (@ians_india) October 12, 2021
(The above story first appeared on LatestLY on Oct 12, 2021 08:30 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
